SG Americas Securities
DCPH

SG Americas Securities’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

SG Americas Securities’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-12,000
Closed -$24K – 3629
2020
Q4 		$24K Buy
+12,000
New +$711K ﹤0.01% 3197

Other funds holding DCPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

SG Americas Securities's DCPH Position: Q1 2024 in Review

SG Americas Securities sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q1 2024, closing a stake of 43,724 shares — an estimated $705K sold.

SG Americas Securities first reported a position in DCPH in Q3 2017 and held it in 18 quarters. The position peaked at $2.58M in Q3 2020. 177 funds tracked by Wall St. Rank hold DCPH as of Q1 2024.

  • SG Americas Securities reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • SG Americas Securities sold 43,724 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q1 2024, an estimated $705K.
  • SG Americas Securities first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q3 2017 and held it in 18 quarters.
  • SG Americas Securities's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $2.58M in Q3 2020.
  • 177 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q1 2024.

Based on SG Americas Securities's 13F filing for Q1 2024, filed 6 May 2024.